Oncology Institute, Inc. (TOI) Cash & Current Investments (2019 - 2026)

Oncology Institute (TOI) has 8 years of Cash & Current Investments data on file, last reported at $30.3 million in Q1 2026.

• Quarterly Cash & Current Investments fell 23.8% year-over-year to $30.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.3 million (down 23.8% YoY) and the FY2025 annual result came in at $33.6 million, down 32.42% from the prior year.
• Cash & Current Investments fell to $30.3 million in Q1 2026, from $33.6 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $95.5 million in Q1 2022 to a low of $27.7 million in Q3 2025.
• A 5-year average of $56.5 million and a median of $49.7 million in 2024 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2022 — Cash & Current Investments surged 685.46% — and 2024, when it tumbled 45.77%.
• Tracing TOI's Cash & Current Investments over 5 years: stood at $73.8 million in 2022, then increased by 12.26% to $82.9 million in 2023, then plunged by 40.05% to $49.7 million in 2024, then slumped by 32.42% to $33.6 million in 2025, then dropped by 9.79% to $30.3 million in 2026.
• The last three Cash & Current Investments figures came in at $30.3 million (Q1 2026), $33.6 million (Q4 2025), and $27.7 million (Q3 2025), per Business Quant data.